Nashrieh Shimi va Mohandesi Shimi Iran

Nashrieh Shimi va Mohandesi Shimi Iran

Design, Synthesis, and Identification of the New Indole-Isoxazole Carbohydrazide Structure

Document Type : Research Article

Authors
Mona Karimi 1
Hassan Kabirifard 1
Seyedeh Sara Mirfazli 2
1 Department of Chemistry, North Tehran Branch, Islamic Azad University, Tehran, I.R. IRAN
2 Department of Medicinal Chemistry, School of Pharmacy, International Vice-Chancellor Office, Iran University of Medical Sciences, Tehran, I.R. IRAN
Abstract
N-acyl hydrazones (NAH) and carbohydrazide derivatives have shown unique therapeutic properties. There is also, a growing interest in designing and evaluating the biological activity of these compounds and their derivatives to investigate their role as a novel structure in medicinal chemistry researches. Considering the importance of carbohydrazide derivatives, the indole-based structures, and isoxazole ring in drug design, The SAR of the active compounds in anti-Alzheimer, anti-cancer, and antiplatelet aggregation activity, and merits further investigation to find the optimal lead structures with maximum biological activity. In this study, the design, synthesis, and identification of the new Indole-isoxazole rings based carbohydrazides were desired. The synthesis started from 3-acetyl Indole, by using various reactants and reaction conditions (solvent, temperature), to obtain 5- (1-methyl-1-indole-3-yl) isoxazole-3-carbohydrazide as a novel compound that would be used as a fundamental structure in drug design. All structures were identified and approved at each step using spectrophotometer methods such as FT-IR, 1H NMR, and Mass.
Keywords
Synthesis
3-Acetylindole
Isoxazole
Carbohydrazide

Subjects

[1] Freidonk ـ Mueschenborn E., Fox A., Resolution of Concentration–Response Differences in Onset of Effect between Subcutaneous and Oral Sumatriptan, Headache,  45: 632–637 (2005).
[2] Verma G.,  Marella A., Shaquiquzzaman M., Akhtar M., Rahmat Ali M., Mumtaz Alam M., A Review: Exploring Biological Activities of Hydrazones, J. Pharm. Bioallied Sci., 6(2): 69–80 (2014).
[3] Popiołek Ł., Hydrazide–Hydrazones as Potential Antimicrobial Agents: Overview of the Literature Since 2010, Med Chem Res., 26(2): 287–301, (2017).
[4] Flynn, B.L.; Flynn, G.P.; Hamel, E.; Jung, M.K. The Synthesis and Tubulin Binding Activity of Thiophene-Based Analogues A-4 Combretastatin. Bioorg, Med. Chem. Lett., 11: 2341–2343 (2001).
[5] Sathler P.C., Lourenҫo A. L., Rodrigues C. R., da silva L.C., Cabral L.M., Jordӑo A. K., Cunha A. C., Vieira M. C., Ferreira V. F., Carvalho-Pinto C. E., Kang H. C., Castro H.C., In Vitro and in Vivo Analysis of the Antithrombotic and Toxicological Profile of New Antiplatelets N-Acylhydrazone Derivatives and Development of Nanosystems Determination of Novel NAH Derivatives Antiplatelet and Nanotechnological Approach, Thromb Res, 134(2): 376-383 (2014).
[6] Fernanda C.F. Brito, Arthur E. Kummerle, Claire Lugnier, Carlos A.M. Fraga, Eliezer J. Barreiro, Ana L, Miranda P., Novel Thienylacylhydrazone Derivatives Inhibit Platelet Aggregation Through Cyclic Nucleotides Modulation and Thromboxane A2 Synthesis Inhibition, Eur. J. Pharmacol,  638: 5-12 (2010).
[7] Chelucci R. C.,  Dutra L. A.,  Lopes Pires M. E.,  Ferreira de Melo T. R.,  Longhin Bosquesi P.,  Chung M. C., Leandro dos Santos J., Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit, Molecules, 19(2): 2089-2099 (2014).
[8] Bala S., Uppal G., Kajal A., Kamboj S., Sharma V., Hydrazones as Promising Lead with Diversity in Bioactivity-Therapeutic Potential in Present Scenario, Int J Pharm Sci Rev Res, 18: 65-74 (2013).
[9] Pais C. G., Zhang X., Marchand C., Neamati N., Cowansage K., Svarovskaia E.S., Pathak V.K., Tang Y., Nicklaus M., Pommier Y., Burke T.R., Structure Activity of 3-Aryl-1,3-diketo-Containing Compounds as HIV-1 Integrase Inhibitors, J. Med. Chem, 45: 3184-3194 (2002).
[10] Mashayekhi V., Haj Mohammad Ebrahim Tehrani K., Amidi S., Kobarfard F., Synthesis of Novel Indole Hydrazone Derivatives and Evaluation of their Antiplatelet Aggregation Activity, Chem Pharm Bull, 61(2): 144-150 (2013).
[11] Nazare M., Essrich M., Will D.W., Matter H., Ritter K., Urmann M., Bauer A., Schreuder H., Dudda A., Czech J., Lorenz M., Laux V., Wehner V, Factor Xa Inhibitors Based on A2-Carboxyindole Scaffold: SAR of Neutral P1 Substituents, Bioorg Med Chem Lett, 14(16): 4191-4195, (2004).
[12] Mirfazli S.S., Shafiee A., Foroumadi A., Kobarfard F., Design, Synthesis and QSAR Study of Arylidene Indoles as Antiplatelet Aggregation Inhibitors, Med. Chem. Res., 25(1): 1-18 (2016).
[13] Mirfazli S. S., Kobarfard F., Firoozpour L., Asadipour A., Esfahanizadeh M., Tabib K., Shafiee A., Foroumadi A., N-Substituted Indole Carbohydrazide Derivatives: Synthesis and Evaluation of Their Antiplatelet Aggregation Activity, DARU Journal of Pharmaceutical Sciences, 22: 65 (2014).
[14] Unsal-Tan O., Ozden K., Rauk A., Balkan A., Synthesis and Cyclooxygenase Inhibitory Activities of Some N-acylhydrazone Derivatives of Isoxazolo[4,5-d] pyridazin-4(5H)-ones, Eur. J. Med. Chem., 45(6): 2345-2352, (2010).
[15] Colley H.E., Muthana M., Danson S.J., Jackson L.V., Brett M.L., Harrison J., Coole S.F., Mason D.P., Jennings R.L., Wong M., Tulasi V., Norman D., Lockey P.M., Williams L., Dossetter A.G., Griffen E.J., Thompson M.J., An Orally Bioavailable, Indole-3-Glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer, J Med. Chem., 58(23): 9309-33 (2015).
[16] Syakaev V., Podyachev S., Buzykin B., Latypov S., Habicher W., Konovalov, NMR Study of Conformation and Isomerization of Aryl- and Heteroarylaldehyde 4-Tert-Butylphenoxyacetylhydrazones, J Mol. Structure., 788(1): 55-62 (2006).
[17] Shiri M.,  Heravi M.m., Zadsirjan V., Nejatinezhad-Arani A., Shintre S.A., Koorbanally N.A., Pseudo-Five-Component Condensation for the Diversity-Oriented Synthesis of Novel Indoles and Quinolines Containing Pseudo-Peptides (Tricarboxamides), Iran. J. Chem. Chem. Eng. (IJCCE), 37(4): 101-115(2017).
[18] de Miranda A.S., Junior W.B., da Silva V.K., Moreira M.S.A., Castro R.P., Sabino J.R., Liao L.M., Lima L.M., Barreiro E.J., Design, Synthesis, Antinociceptive And Anti-Inflammatory Activities of Novel Piroxicam Analogues, Molecules, 17: 14126-14145 (2012).